A recent meta-analysis [121] further explored the correlations between serum chemerin levels and NAFLD (steatosis and/or NASH) and its specific hepatic histologic lesions (liver steatosis, lobular and portal inflammation, and fibrosis). This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatotic liver disease.